Quest Diagnostics
Update in progressDGX (NYSE)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryDiagnostics & Research
Quest Diagnostics Incorporated delivers diagnostic testing and related information services in the United States. It provides routine, advanced and specialized clinical testing, anatomic pathology, and other diagnostic information services under the Quest Diagnostics brand and through AmeriPath, Dermpath Diagnostics, ExamOne and Quanum. Serving physicians, hospitals, patients, payers, employers and health plans, it operates laboratories, service centers, phlebotomy networks and digital health solutions. Founded 1967, Secaucus, NJ.
Company score
- Sentiment
- 0.98
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.14
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.97
- Governance
- 0.32
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.40
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.69
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNYSE (NYQ)
- LocationUnited States
- CEOMr. James E. Davis
- Founded1967
- Employees46,000
- Websitewww.questdiagnostics.com
Identifiers
- ISINUS74834L1008
- FIGIBBG000BN84F3
- LEI8MCWUBXQ0WE04KMXBX50
- CUSIP74834L100
- CIK0001022079